Reclast

List of products in the National Drug Code with proprietary name reclast. This medication is used to treat a certain type of bone disease (Paget's disease) that causes abnormal and weak bones. Zoledronic acid is also used to treat bone loss (osteoporosis) in men and in women after menopause who are at high risk of having broken bones (fractures). It may also be used to treat or prevent osteoporosis in people who are taking corticosteroid medications (such as prednisone) for long periods. It works by slowing the breakdown of bone and keeping bones strong. It also helps to reduce the risk of broken bones (fractures). This medication belongs to a class of drugs known as bisphosphonates. Another zoledronic acid product is used to treat bone problems that may occur with cancer. The 2 products should not be used together.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0078-0435Reclast Zoledronic AcidInjection, SolutionIntravenousNovartis Pharmaceuticals CorporationHuman Prescription Drug